Christopher Cavallaro, MS has more than 22 years of experience in clinical research working both on the Pharmaceutical and Clinical Research Organization (CRO) side.  He brings to Veralox experience in-depth knowledge of the clinical trial process, from study start-up to closeout, and has demonstrated a strong aptitude in project management, patient safety, patient recruitment, site feasibility assessments, vendor management and the management of Data Monitoring Committees and Endpoint Adjudication Committees. His experience spans across a range of therapeutic areas, including but not limited to Respiratory, Oncology, Cardiovascular, CNS, and Women’s Health, reflecting his versatility and adaptability in the pharmaceutical research landscape.

Christopher earned a Bachelor of Arts from La Salle University, followed by a master’s degree in biomedical sciences from the Philadelphia College of Osteopathic Medicine. After receiving his master’s degree, Christopher worked for Wyeth (Pfizer), AstraZeneca, Pharmanet, ACI Clinical, WCG Clinical and inSeption.  

• 

  Director, Clinical Operations in Veralox Therapeutics

  Developing new therapies for life-threatening immuno-inflammatory diseases